SwanBio Therapeutics
Latest round
- Series B
Last raised
- May 2022
Total raised
- $76M
Investors
- 2
About SwanBio Therapeutics
SwanBio Therapeutics, Inc. is a biotechnology company focused on developing innovative gene therapies for rare genetic diseases.SwanBio Therapeutics, Inc. specializes in gene therapies for rare genetic diseases. Founded in 2018 in the US, the company has undergone strategic shifts since its inception. The founders, Florian Eichler, Karen Kozarsky, and Rachel Salzman, have backgrounds in biotechnology and have been involved in multiple ventures.SwanBio Therapeutics develops groundbreaking gene therapies for conditions such as Gaucher disease, Parkinson's disease, and various forms of dementia. Their core product offerings are designed to enhance gene expression and aim to provide transformative results with a single dose. Targeting the North American and European healthcare markets, SwanBio focuses on partnerships with hospitals and specialized providers to improve treatment options for patients with chronic diseases.SwanBio Therapeutics' revenue model is based on strategic partnerships and collaborations with healthcare institutions. The company engages in business-to-business relationships, negotiating pricing arrangements for their therapies aimed at conditions like Gaucher disease and Parkinson's. The company is focused on launching new products tailored for treating debilitating conditions, with specific timelines and details yet to be disclosed. Additionally, SwanBio aims to expand its reach within North America and Europe, solidifying its presence in regions with a high demand for innovative gene therapies.
Who invested in SwanBio Therapeutics
2 investors across 3 rounds
See all investors in SwanBio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SwanBio Therapeutics
Who invested in SwanBio Therapeutics?
SwanBio Therapeutics has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SwanBio Therapeutics raised?
SwanBio Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SwanBio Therapeutics last raise money?
SwanBio Therapeutics's most recent round on record is a Series B, in May 2022.
What does SwanBio Therapeutics do?
SwanBio Therapeutics is a pharmaceuticals company.
Where is SwanBio Therapeutics headquartered?
SwanBio Therapeutics is headquartered in US.
Which VCs invest in companies like SwanBio Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at SwanBio Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like SwanBio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.